Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential

American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

Mark G. Kris, Paul J. Hesketh, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2006 · 743 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

Richard J. Gralla, Loretta M. Itri, Sharon E. Pisko et al. · New England Journal of Medicine · 1981 · 710 citations

Medicine, Pharmacology, Pharmacotherapy +17

A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study

Rudolph M. Navari, Lawrence H. Einhorn, Steven D. Passik et al. · Supportive Care in Cancer · 2005 · 147 citations

Medicine, Oncology, Pharmacotherapy +16

Randomized, Double-Blind, Dose-Finding Study of Dexamethasone in Preventing Acute Emesis Induced by Anthracyclines, Carboplatin, or Cyclophosphamide:

Journal of Clinical Oncology · 2004 · 72 citations · Full text

Medicine, Oncology, Pharmacology +16

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.

James F. Bishop, I. N. Olver, M. Wolf et al. · Journal of Clinical Oncology · 1984 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +12